OPTmizing Advanced Stage HodgkIn LymphoMa patIentS Therapy

NCT03527628 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

220

Enrollment

OTHER

Sponsor class

Conditions

Classical Hodgkin Lymphoma
Hodgkin Lymphoma (Category)
Hodgkin Disease
Hodgkin Lymphoma

Interventions

DRUG: Adriamycin
DRUG: Cyclophosphamide
DRUG: Vinblastine
DRUG: Dacarbazine
DRUG: Brentuximab Vedotin
DRUG: ABVD

Sponsor

King Abdullah International Medical Research Center